Valerie Odegard

Valerie Odegard

Company: Silverback Therapeutics

Job title: President & Chief Scientific Officer


Immunomodulatory Antibody Conjugates for the Treatment of Cancer & Chronic Viral Infections 2:00 pm

An overview of Silverback’s ImmunoTAC (Immunomodulatory Targeted Antibody Conjugate) technology platform Discussing the discovery and development of ImmunoTAC molecules containing a TLR8 agonist payload designed to stimulate local activation of myeloid cells Examining how broad and versatile potential of the ImmunoTAC platform is exemplified by oncology (SBT6050 and SBT6290) and virology (SBT8230) development candidatesRead more

day: day 2 opps
day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.